ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 121 filers reported holding ANI PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $745,084 | +7.9% | 12,833 | 0.0% | 0.00% | +100.0% |
Q2 2023 | $690,800 | +44.5% | 12,833 | +6.6% | 0.00% | 0.0% |
Q1 2023 | $477,951 | +3.0% | 12,033 | +4.3% | 0.00% | 0.0% |
Q4 2022 | $463,973 | +100.0% | 11,533 | +59.4% | 0.00% | 0.0% |
Q3 2022 | $232,000 | +0.4% | 7,233 | -7.2% | 0.00% | 0.0% |
Q2 2022 | $231,000 | +5.5% | 7,793 | 0.0% | 0.00% | – |
Q1 2022 | $219,000 | -39.0% | 7,793 | 0.0% | 0.00% | -100.0% |
Q4 2021 | $359,000 | -17.1% | 7,793 | -40.9% | 0.00% | 0.0% |
Q3 2021 | $433,000 | -6.3% | 13,183 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $462,000 | -2.9% | 13,183 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $476,000 | +24.3% | 13,183 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $383,000 | +3.0% | 13,183 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $372,000 | -12.7% | 13,183 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $426,000 | -20.7% | 13,183 | 0.0% | 0.00% | -50.0% |
Q1 2020 | $537,000 | -33.9% | 13,183 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $813,000 | – | 13,183 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AIGH Capital Management LLC | 272,801 | $15,838,826 | 7.50% |
Global Alpha Capital Management Ltd. | 525,528 | $30,512,156 | 3.06% |
Rubric Capital Management LP | 847,011 | $49,177,459 | 1.84% |
Ranger Investment Management | 426,848 | $24,782,795 | 1.64% |
Parkman Healthcare Partners LLC | 111,802 | $6,491,224 | 1.19% |
MARATHON CAPITAL MANAGEMENT | 71,670 | $4,161,160 | 1.05% |
Mesirow Financial Investment Management, Inc. | 3,862 | $224,228 | 0.98% |
Deep Track Capital, LP | 400,000 | $23,224,000 | 0.90% |
1492 Capital Management LLC | 18,178 | $1,055,415 | 0.68% |
Phocas Financial Corp. | 75,213 | $4,367,000 | 0.64% |